These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25214785)

  • 1. Interleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.
    Almer G; Summers KL; Scheicher B; Kellner J; Stelzer I; Leitinger G; Gries A; Prassl R; Zimmer A; Mangge H
    Int J Nanomedicine; 2014; 9():4211-22. PubMed ID: 25214785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques.
    Almer G; Wernig K; Saba-Lepek M; Haj-Yahya S; Rattenberger J; Wagner J; Gradauer K; Frascione D; Pabst G; Leitinger G; Mangge H; Zimmer A; Prassl R
    Int J Nanomedicine; 2011; 6():1279-90. PubMed ID: 21753879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.
    Almer G; Frascione D; Pali-Schöll I; Vonach C; Lukschal A; Stremnitzer C; Diesner SC; Jensen-Jarolim E; Prassl R; Mangge H
    Mol Pharm; 2013 Jan; 10(1):175-86. PubMed ID: 23176185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
    Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
    Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 6. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.
    Wu Q; Pan W; Wu G; Wu F; Guo Y; Zhang X
    Atherosclerosis; 2023 Mar; 369():17-26. PubMed ID: 36863196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles.
    Tong W; Hui H; Shang W; Zhang Y; Tian F; Ma Q; Yang X; Tian J; Chen Y
    Theranostics; 2021; 11(2):506-521. PubMed ID: 33391489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging.
    Jacobin-Valat MJ; Laroche-Traineau J; Larivière M; Mornet S; Sanchez S; Biran M; Lebaron C; Boudon J; Lacomme S; Cérutti M; Clofent-Sanchez G
    Nanomedicine; 2015 May; 11(4):927-37. PubMed ID: 25684334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound/Optical Dual-Modality Imaging for Evaluation of Vulnerable Atherosclerotic Plaques with Osteopontin Targeted Nanoparticles.
    Li S; Gou T; Wang Q; Chen M; Chen Z; Xu M; Wang Y; Han D; Cao R; Liu J; Liang P; Dai Z; Cao F
    Macromol Biosci; 2020 Feb; 20(2):e1900279. PubMed ID: 31885210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
    Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
    Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.
    De Vos J; Mathijs I; Xavier C; Massa S; Wernery U; Bouwens L; Lahoutte T; Muyldermans S; Devoogdt N
    Mol Imaging Biol; 2014 Oct; 16(5):690-8. PubMed ID: 24687730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
    Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques.
    He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W
    Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
    Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
    ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.
    van Tilborg GA; Vucic E; Strijkers GJ; Cormode DP; Mani V; Skajaa T; Reutelingsperger CP; Fayad ZA; Mulder WJ; Nicolay K
    Bioconjug Chem; 2010 Oct; 21(10):1794-803. PubMed ID: 20804153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory cytokine IL10 loaded cRGD liposomes for the targeted treatment of atherosclerosis.
    Li J; Ding F; Qian X; Sun J; Ge Z; Yang L; Cheng Z
    J Microencapsul; 2021 Sep; 38(6):357-364. PubMed ID: 33048003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.
    Li D; Patel AR; Klibanov AL; Kramer CM; Ruiz M; Kang BY; Mehta JL; Beller GA; Glover DK; Meyer CH
    Circ Cardiovasc Imaging; 2010 Jul; 3(4):464-72. PubMed ID: 20442371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.
    Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X
    Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
    Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y
    Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.